First human tests begin for new drug candidate
NCT ID NCT07471932
Summary
This is the first study in humans to test a new drug called LAD106. It aims to find out if the drug is safe, how the body processes it, and what side effects it might cause. The study will involve about 93 healthy adult volunteers who will receive either the drug or a placebo. This is an early, foundational step to see if the drug is safe enough for future testing in people with specific diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Centre for Human Drug Research (CHDR) Phase 1 Unit
RECRUITINGLeiden, Netherlands
Conditions
Explore the condition pages connected to this study.